With $200M in­vest­ment, No­var­tis builds out ra­di­oli­gand man­u­fac­tur­ing at two sites

No­var­tis is putting $200 mil­lion in­to its ra­di­oli­gand ther­a­py man­u­fac­tur­ing ca­pa­bil­i­ties with a new site in Cal­i­for­nia and the ex­pan­sion of an ex­ist­ing site in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER